Search results | sanofi


Partnering Agreements with Sanofi

This report provides all the information you require to better understand Sanofi and its partnering interests and activities over the past seven years.


Both, Actavis and Sanofi competing for Omega Pharma

Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland.


Sanofi is a top pharmaceutical company based in Paris, France

Sanofi seeking to dispose of mature product portfolio

Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion

Sanofi to divest portfolio of mature drugs for $7 billion

Sanofi SA is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas.

Allergan looks to Sanofi or J&J for acquisition

Allergan has contacted companies including Sanofi and Johnson & Johnson to see if either would be interested in acquiring the Botox maker, said people with knowledge of the matter, as it explores its options after receiving an unsolicited $45.7 billion bid from Valeant Pharmaceuticals International Inc.

Dealtalk: ViroPharma Said to Hire Goldman Amid Sanofi Interest

According to dealtalk, ViroPharma began working with Goldman Sachs Group Inc. on a possible auction after fielding an unsolicited approach.

Dealtalk: Sanofi could acquire L’Oreal’s stake, buy more of Regeneron

According to dealtalk, repurchasing L’Oreal’s 9 percent stake in Sanofi might make sense for the French drugmaker if the $12 billion holding is put up for sale.

Pharma rumor mill: Sanofi, Novartis & GlaxoSmithKline all in race to buy Elder Pharma

Elder Pharmaceuticals shares rose after reports in the pharma rumor mill that Sanofi, Novartis & GlaxoSmithKline are all in race for their acquisition.

Sanofi Partnering: Sanofi values innovative partnerships

Sanofi is a top pharma company active in partnering, licensing and M&A in pharmaceuticals, biotech and animal health

Sanofi: Partnering activity 2005-2013

Sanofi announced over 274 partnering / licensing deals since 2005, with over 33 deals in 2012 alone


Sorry, your search returned no results.


Sanofi Pasteur and VBI Vaccines in formulation pact

VBI Vaccines has entered into a research collaboration with Sanofi Pasteur to apply VBI’s LPV (Lipid Particle Vaccine) formulation technology

Sanofi and Evotec in drug discovery alliance

Evotec announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi

Sanofi and Lead Pharma in autoimmune disorders pact

Sanofi has entered into a research collaboration and license agreement with Lead Pharma to discover, develop and commercialize small-molecule therapies

Sanofi and Adimab enter multi-target discovery pact

Adimab announced a multi-target discovery and optimization collaboration with Sanofi

Sanofi and Vect-Horus collaborate to transport therapeutic antibodies into brain

VECT-HORUS announced the signing of a scientific collaboration agreement with SANOFI

Sanofi and Boehringer Ingelheim in antibody manufacturing pact

Boehringer Ingelheim and Sanofi enter into an alliance to extend Sanofi’s manufacturing capacity network for therapeutic monoclonal antibodies

Sanofi and Evotec in drug discovery pact

Evotec has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years

Selecta and JDRF extend its pharma partnership with Sanofi

Selecta Biosciences JDRF have extended their pharma partnership and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes.

Intrexon pharma alliances with Sanofi Chimie

Intrexon Corporation has entered into an Exclusive Channel Collaboration with Sanofi Chimie to develop an enhanced production process for a specific family of its marketed Active Pharmaceutical Ingredients through Sanofi’s current manufacturing operations in France.

Unilife signs a pharma partnership with Sanofi

Unilife and Sanofi announce a pharma partnership for $50 million.